Spotlight On... Illumina shares details of semiconductor-based sequencing device; Big Pharma consortium to share tox data; Israel picks health data sharing tech; and more...

Illumina CEO Jay Flatley

Illumina ($ILMN) CEO Jay Flatley has shared details of Project Firefly, the genomic leader's move into semiconductor-based sequencing. At a presentation at Advances in Genome Biology and Technology attended by GenomeWeb, Flatley said the sequencing device is a CMOS sensor with nanowells. In early internal tests, the device achieved 99% raw read accuracy, putting it in the same league as the HiSeq X system. Article (reg. req.)

> Big Pharma consortium TransCelerate BioPharma set up a group to share toxicology data. Release

> Israel's Ministry of Health picked Safe-T Box 6.0 to support secure sharing of healthcare data. Statement

> Repositive has secured access to expression data through a partnership with Xpressomics. Item

> Cenduit introduced an interactive response technology system professional services unit. More

> Rondaxe Enterprises released software to help contract manufacturers predict the cost of production projects. Article

> Octapharma picked E-WorkBook 10 from IDBS as its web-based electronic laboratory notebook. Post

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.